Advancing Therapies for Patients

Find a clinical trial


page image
shadow image

Text Size

minus image

plus image

plus image


Print image

Email a Friend


Find a clinical trial

Personalising Treatment in Breast Cancer


Dr Alison Jones, Principal Investigator at SCRI UK, and other experts talk about personalising treatment in breast cancer through targeting the BRCA mutation. They focus on PARP inhibitors and, in particular, talazoparib, which is being studied in the EMBRACA trial

Latest Videos

watch the latest videos.

Learn more


news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals